NIAID emergency R21 and R01 FOAs for COVID-19 research

May 5, 2020

Dear CFAR Investigators,

In case you are not already aware, additional opportunities have been posted for SARS-CoV-2 research. NIAID published the emergency R21 and R01 FOAs for COVID-19 research recently. Please share with all who may be interested.

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).

  • PAR-20-177, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, Clinical Trial Not Allowed)
  • PAR-20-178, Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01, Clinical Trial Not Allowed)